Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery

Kidney International

Volumn 64, Issue 3, 2003, Pages 1046-1049

  Winkelmayer, Wolfgang C ^a   Glynn, Robert J ^a   Levin, Raisa ^a   Avorn, Jerry ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cardiac surgery; Drug safety; Epidemiology; Hetastarch; Kidney function

Indexed keywords

HETASTARCH;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEMOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0042431932     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00186.x     Document Type: Article

References (20)

1. BOLDT J, LENZ M, KUMLE B, PAPSDORF M: Volume replacement strategies in intensive care units: results from a postal survey. Intensive Care Med 24:147-151, 1998
2. CHOI PT, YIP G, QUINONEZ LG, COOK DJ: Cristalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med 27:200-210, 1999
3. HASKELL LP, TANNENBERG AM: Elevated urinary specific gravity in acute oliguric renal failure due to hetastarch administration. N Y State J Med 88:387-388, 1988
4. WALDHAUSEN P, KIESEWETTER H, LEIPNITZ G, et al: Hydroxyethyl starch-induced transient renal failure in preexisting glomerular damage. Acta Med Austriaca 18:52-55, 1991
5. DICKENMANN MJ, FILIPOVIC M, SCHNEIDER MC, BRUNNER FP: Hydroxyethylstarch-associated transient acute renal failure after epidural anaesthesia for labour analgesia and Caesarean section [letter]. Nephrol Dial Transpl 13:2706, 1998
6. DE LABARTHE A, JACOBS F, BLOT F: Acute renal failure secondary to hydroxyethylstarch administration in a surgical patient. Am J Med 111:417-418, 2001
7. LEGENDRE C, THERVET E, PAGE B, et al: Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 342:248-249, 1993
8. CITTANOVA ML, LEBLANC I, LEGRENDRE C, et al: Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 348:1620-1622, 1996
9. DEMAN A, PEETERS P, SENNESAEL J: Hydroxyethyl starch does not impair immediate renal function in kidney transplant recipients: A retrospective, multicentre analysis. Nephrol Dial Transplant 14:1517-1520, 1999
10. KUMLE B, BOLDT J, PIPER S, et al: The influence of different intravascular volume replacement regimens on renal function in the elderly. Anaesth Analg 89:1124-1130, 1999
11. SCHORTGEN F, LACHERADE J-C, BRUNEEL F, et al: Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: A multicentre randomized study. Lancet 357:911-916, 2001
12. STANDL T, LIPFERT B, REEKER W, et al: Acute effects of complete blood exchange with ultra purified hemoglobin solution or hydroxyethyl starch on liver and kidney in the animal model. Anaesthesiol Intensivmed Notfallmed Schmerzther 31:354-361, 1996
13. COCKROFT DW, GAULT MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
14. MORDCHAI R, BROSH D, ZOHAR L, et al: Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus: A randomized, controlled trial. Ann Int Med 128:982-988, 1998
15. BJÖRCK S, MULEC H, JOHNSEN SA, et al: Renal protective effect of enalapril in diabetic nephropathy. Br Med J 304:339-343, 1992
16. AMERICAN DIABETES ASSOCIATION: Position statement: Diabetic nephropathy. Diab Care 25 (Suppl):S85-S89, 2002
17. GOSLING P, RITTOO D, MANJI M, et al: Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis [letter]. Lancet 358:581, 2001
18. GOOET G: Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis [letter]. Lancet 358:581, 2001
19. BOLDT J: Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis [letter]. Lancet 358:581-582, 2001
20. BERNAL W, WENOON JA: Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis. Lancet 358:583, 2001